C3 and schizophrenia: Despite the strong evidence for hyperactivation of the classical complement pathway in schizophrenia, levels of C3 were not significantly higher in our individuals with schizophrenia than in healthy controls, which is consistent with a meta-analysis comparing individuals with schizophrenia and controls24 and with a study of individuals with first-episode psychosis43.